Susquehanna International Group’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
Other funds holding CODX
PAG
SAM
SS
HWA
DB
Susquehanna International Group's CODX Position: Q1 2026 in Review
Susquehanna International Group sold out of Co-Diagnostics (CODX) in Q1 2026, closing a stake of 1,642 shares — an estimated $8.3K sold.
Susquehanna International Group first reported a position in CODX in Q1 2020 and held it in 24 quarters. The position peaked at $4.13M in Q3 2021. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.
- Susquehanna International Group reported no remaining Co-Diagnostics position as of Q1 2026 after selling out during the quarter.
- Susquehanna International Group sold 1,642 Co-Diagnostics shares in Q1 2026, an estimated $8.3K.
- Susquehanna International Group first reported a position in Co-Diagnostics in Q1 2020 and held it in 24 quarters.
- Susquehanna International Group's Co-Diagnostics position peaked at $4.13M in Q3 2021.
- 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.